ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,676, issued on March 24, was assigned to CellDrop Biosciences Inc. (Laramie, Wyo.).
"Hydrogel particle encapsulated viable cells for in vivo regenerative treatment" was invented by Wallace Chick (Greenwood Village, Colo.) and Benjamin Noren (Laramie, Wyo.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A composition for tendon and ligament regeneration includes a biologically compatible hydrogel suspension having spherical droplets. The spherical droplets have a diameter of about 100 micro metre to about 300 micro metre and a plurality of cells. The cells include marrow-derived mesenchymal stem cells (MSCs) with an average viability of about 90% or ...